/Investor DB

Colorcon Ventures — Full Portfolio

14 tracked investments · listed companies and verified rows first

Apprenticeapprentice.ioin𝕏

Apprentice builds AI agents and cloud manufacturing software for regulated production environments such as pharmaceutical and life sciences manufacturing.

Advanced ManufacturingAI & Machine LearningSaaSJersey City, US

Angelo Stracquatanio(Executive Officer, Director, Promoter)in

Co-investorsICONIQ GrowthAlkeon InnovationCerity Partners VenturesGFR FundHemi Ventures, LlcICONIQ+5 more

Cerity Partnersceritypartners.com

Cerity Partners provides investment management and wealth advisory services to individuals and families, offering full portfolio management, coordination with existing advisors, or advisory guidance.

Fintech

Jessica Farrell(Partner)inKurt Miscinski(CEO & President)in

Co-investorsCerity Partners VenturesGenstarLightyearW Capital PartnersWarburg PincusWest Coast Financial

I2 Therapeuticsi2obio.comin

A biopharmaceutical company developing a pipeline of long-acting therapeutic candidates, including GLP-1 receptor agonists, amylin DACRAs, a PYY receptor agonist, and a glucagon receptor agonist.

BiotechSaratoga, US

Mitragotri Mitragotri(Executive Officer, Director)Ravi Srinivasan(Executive Officer, Director)in

Co-investors7G BioVenturesCerity Partners VenturesHikma VenturesSanofi VenturesJDRF T1D Fund

Mend Nutrition, Inc.mend.mein𝕏

Mend develops clinically formulated nutrition products designed to support healing and recovery, marketed as "food as medicine." It partners with physicians to offer digital health coaching, remote patient monitoring, and nutritional formulas for patients across stages of recovery.

Digital HealthHealthtechWellness & FitnessNew York, US

Eziah Syed(Executive Officer, Director)inJ Whitney Stevens(Founder)inDaniel Ripma(Executive Officer, Director)Paul Roscoe(Executive Officer, Director)inBill Hagaman(Director)

BoardJustin Kamine(Director)

Co-investorsAlumni VenturesCerity Partners VenturesiSelect FundTech Council Ventures

Nourishedget-nourished.com

Nourished makes personalised, 3D-printed-style nutrient gummy stacks that customers customise to their own needs, formulated with vegan, sugar-free ingredients by in-house nutritionists.

ConsumerDirect to ConsumerFoodTechWellness & FitnessBirmingham, GB

Melissa Snover(Founder)

Co-investorsCerity Partners VenturesCIBUS ENTERPRISE FUND II LPFuture Planet CapitalRiverPark VenturesSanno Capital GmbHADM Ventures

Novome Biotechnologiesnovomebio.comNov 2016

South San Francisco biotech engineering commensal gut bacteria into controllable live therapeutics for chronic diseases.

Daly City, US

Weston Whitaker(Executive Officer, Director, Promoter)William DeLoache(Director)Samuel Smits(Director)

BoardElizabeth Stanley(Director)

Co-investorsAlta PartnersCerity Partners Ventures5AM VenturesAlexandriaDCVC (Data Collective)DCVC Bio+2 more

Numerion Labsnumerionlabs.aiin𝕏

Numerion combines drug discovery expertise with machine learning and computational chemistry.

AI & Machine LearningBiotechHealthtechMedical DevicesSan Francisco, US

Alex Levy(Founder)inIzhar Wallach(Founder)inSteve Worland(CEO)inPamela Tsuruda(VP, Biology)Mark Sabat(VP, Medicinal Chemistry)inKate Stafford(VP, Machine Learning)in

Co-investorsB Capital GroupB4 CapitalDCVC (Data Collective)Dolby Family VenturesNEXT CanadaY Combinator+12 more

Phytolonphytolon.cominMay 2026

Phytolon produces natural food colors derived from baker's yeast fermentation technology, offering vivid hues with heat stability and clean label credentials for food manufacturers.

BiotechClimate TechFoodTechNew Materials

Halim Jubran(Co-founder & CEO)inTal Zeltzer(Co-founder & CTO)in

Co-investorsCIBUS ENTERPRISE FUND II LPTrendlines Group

Syntis Biosyntis.bioin𝕏

Syntis Bio develops oral therapies that use the biology of the small intestine to treat conditions ranging from rare genetic disorders to common diseases.

BiotechDeep TechDigital HealthHealthtechBoston, US

Rahul Dhanda(Executive Officer, Director)inCarlo Giovanni Traverso(Director)Robert Langer(Director)

BoardTeymour Boutros-Ghali(Director)inMartin Madaus(Director)

Co-investorsBill & Melinda Gates FoundationBold Capital PartnersCerity Partners VenturesPortal InnovationsSafar PartnersSky9 Capital

Unnatural Productsunnaturalproducts.comin𝕏Sep 2019

Unnatural Products is a drug discovery platform company that develops synthetic macrocycles to target previously undruggable disease targets.

AI & Machine LearningBiotechDeep TechMedical DevicesSanta Cruz, US

Cameron Pye(Co-Founder & CEO)inJoshua Schwochert(Co-Founder & CSO)in

BoardVasudev Bailey(Director)in

Co-investorsAbstract VenturesArtis VenturesAsset Management CompanyBetter Ventures Central LlcBlue Bear VenturesDroia Ventures+9 more

Vedanta Biosciencesvedantabio.comin𝕏

Vedanta Biosciences is a clinical-stage biotech developing Live Biotherapeutic Products (LBP) based on defined consortia of bacteria to treat serious gastrointestinal diseases, with an initial focus on preventing recurrent Clostridium difficile infection.

BiotechHealthtechCambridge, US

Bernat Olle(Executive Officer, Director)inDaniel Couto(Executive Officer)inMark Mullikin(Executive Officer)inJeffrey Silber(Executive Officer)inChristopher Viehbacher(Director)

BoardJohn LaMattina(Director)in

Co-investorsAMR Action FundK2 HealthVenturesSalica InvestmentsSeventure PartnersBNP ParibasBNP Paribas Asset Management Europe+2 more

VeriSIM Lifeverisimlife.comin𝕏Jan 2022

VeriSIM uses machine learning and computational simulation to accelerate drug development, replacing traditional trial-and-error experimentation with computational prediction to improve success rates and reduce animal testing.

AI & Machine LearningBiotechDigital HealthMedical DevicesSan Francisco, US

Jo Varshney(Founder & Chief Executive Officer)inDr. Vivek Gupta, Ph.D.(Scientific Co-Founder)

Co-investorsAmplify PartnersCerity Partners VenturesDeepwater Asset ManagementIntel CapitalLoup VenturesNextwave [X] Partners+8 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Remedy HealthThornhill

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.